Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CGEn (Canada's Genomics Enterprise) is a national platform for genome sequencing and analysis, established in 2014 to provide a coordinated network of genomic infrastructure across Canada. It operates as a consortium of three leading nodes: The Centre for Applied Genomics at SickKids, the McGill Genome Centre, and Canada's Michael Smith Genome Sciences Centre at BC Cancer. The enterprise provides high-throughput sequencing, advanced bioinformatics, and data management services to support large-scale research in rare diseases, oncology, and infectious diseases. CGEn is primarily funded by the Canada Foundation for Innovation and Genome Canada, playing a critical role in advancing precision medicine and genomic research across the country. By integrating resources and expertise, CGEn enables Canadian researchers to conduct world-class genomic studies that drive clinical innovation and personalized healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canada's Genomics Enterprise.